β-D-Glucopyranosiduronic acid, 5-bromo-6-chloro-1H-indol-3-yl, compd. with cyclohexanamine (1:1) – (144110-43-0)

144089-96-3, N-(9-((2R, 3R, 4R, 5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3-fluoro-4-hydroxytetrahydrofuran-2-yl)-6-oxo-6, 9-dihydro-1H-purin-2-yl)isobutyramide, Guanosine, 5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-deoxy-2'-fluoro-N-(2-methyl-1-oxopropyl)-, 5'-O-DMT-N2-ISOBUTYRYL-2'-FLUORO-2'-DEOXYGUANOSINE, N-[9-[(2R, 3R, 4R, 5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-3-fluoro-4-hydroxyoxolan-2-yl]-6-oxo-1H-purin-2-yl]-2-methylpropanamide, N-{9-[(2R, 3R, 4R, 5R)-5-{[bis(4-methoxyphenyl)(phenyl)methoxy]methyl}-3-fluoro-4-hydroxyoxolan-2-yl]-6-oxo-6, 9-dihydro-1H-purin-2-yl}-2-methylpropanamide, MFCD15145247, SCHEMBL18797904, C35H36FN5O7, DTXSID701120004, HG1082, AKOS027336567, AS-74588, CS-0172983, 5'-O-(4, 4'-Dimethoxytrityl)-2'-fluoro-N2-isobutyryl-2'-deoxyguanosine, 5''-O-(4, 4''-Dimethoxytrityl)-2''-fluoro-N2-isobutyryl-2''-deoxyguanosine, 5a(2)-O-[Bis(4-methoxyphenyl)phenylmethyl]-2a(2)-deoxy-2a(2)-fluoro-N-(2-methyl-1-oxopropyl)guanosine, N-(9-((2R, 3R, 4R, 5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3-fluoro-4-hydroxytetrahydrofuran-2-yl)-6-oxo-6, 9-dihydro-3H-purin-2-yl)isobutyramide, N-{9-[(2R, 3R, 4R, 5R)-5-{[bis(4-methoxyphenyl)(phenyl)methoxy]methyl}-3-fluoro-4-hydroxyoxolan-2-yl]-6-oxo-1H-purin-2-yl}-2-methylpropanamide